Loading…

Effects of Cot expression on the nuclear translocation of NF-κB in RBL-2H3 cells

Cot is a serine/threonine protein kinase and is classified as a mitogen-activated protein (MAP) kinase kinase kinase. Overexpression of this protein has been shown to activate the extracellular signal-regulated kinase, the c-Jun N-terminal kinase, and the p38 MAP kinase pathways and to stimulate NF-...

Full description

Saved in:
Bibliographic Details
Published in:Molecular immunology 2007-03, Vol.44 (7), p.1490-1497
Main Authors: Chikamatsu, Satomi, Furuno, Tadahide, Kinoshita, Yosuke, Inoh, Yoshikazu, Hirashima, Naohide, Teshima, Reiko, Nakanishi, Mamoru
Format: Article
Language:English
Subjects:
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:Cot is a serine/threonine protein kinase and is classified as a mitogen-activated protein (MAP) kinase kinase kinase. Overexpression of this protein has been shown to activate the extracellular signal-regulated kinase, the c-Jun N-terminal kinase, and the p38 MAP kinase pathways and to stimulate NF-AT and NF-κB-dependent transcription. Here we have shown that Cot kinase activity is intimately involved in the high affinity receptor for IgE (FcɛRI)-mediated nuclear translocation of NF-κB1 independent of NF-κB-inducing kinase (NIK) in rat basophilic leukemia (RBL-2H3) cells. A transfected green fluorescent protein-tagged NF-κB1 (GFP-NF-κB1) resided in the cytoplasm in RBL-2H3 cells and it remained in the cytoplasm even when Cot tagged with red fluorescent protein (Cot-RFP) was co-expressed. Western blotting analysis showed that IκB kinases (IKKs) were expressed in RBL-2H3 cells but NIK was not. GFP-NF-κB1 translocated from the cytoplasm to the nucleus after the aggregation of FcɛRI in Cot-transfected cells but not in kinase-deficient Cot-transfected cells. This finding gives a new insight into the role of Cot in the FcɛRI-mediated NF-κB activation in mast cells.
ISSN:0161-5890
1872-9142
DOI:10.1016/j.molimm.2006.09.002